Par Pharmaceutical, headquartered in Chestnut Ridge, NY, is an operating company of Endo International plc. Par develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products. The Par facilities located in India support our U.S. business in key areas, such as manufacturing and R&D.